The Financial Times earlier reported, citing a US official, that China was trying to get its hands on advanced technologies developed in the United States, including gene editing and human performance enhancement technologies, as well as brain-machine interfaces.
“Oh, of course private businesses can collude with the government to ensure that you have no access to employment, goods, and services and are marginalized from society if you don’t share their values — don’t you know that?”
The U.S. Supreme Court will hear arguments Jan. 7 in cases challenging two of the Biden administration’s COVID-19 vaccine mandates. Those mandates would apply to more than 100 million Americans who work at private-sector businesses and health care facilities.
In a recent Washington Post op-ed, three retired generals, Paul Eaton, Antonio Taguba, and Steven Anderson warn of a supposedly impending coup should Donald Trump be elected in 2024.
American corporate media love catchphrases that they all repeat in unison, across network and cable television and through social media. One recent example is “viral blizzard” referring to the omicron variant of COVID.
The US Senate has passed its National Defense Authorization Act (NDAA) military spending bill for the fiscal year of 2022, setting the budget at an astronomical $778 billion by a vote of 89 to 10.
Newsweek review of financial filings in Congress has found that lawmakers who are driving legislation to protect Uyghurs in China are also invested—either directly in the form of stocks, or indirectly via mutual funds—in major companies tied to the oppression in Xinjiang.
